---
title: Study of the Effectiveness of Vestibular Stimulation as a Coadjuvant Treatment in Major Depression
nct_id: NCT01399671
overall_status: COMPLETED
phase: NA
sponsor: Fuerza Aérea de Chile
study_type: INTERVENTIONAL
primary_condition: Depression
countries: Chile
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01399671.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01399671"
ct_last_update_post_date: 2012-03-05
last_seen_at: "2026-05-12T06:34:44.285Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Study of the Effectiveness of Vestibular Stimulation as a Coadjuvant Treatment in Major Depression

**Official Title:** Clinical Randomized Trial to Evaluate the Efficacy of Vestibular Stimulation as Coadjuvant Therapy in Major Depression

**NCT ID:** [NCT01399671](https://clinicaltrials.gov/study/NCT01399671)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 80
- **Lead Sponsor:** Fuerza Aérea de Chile
- **Collaborators:** Pontificia Universidad Catolica de Chile
- **Conditions:** Depression, Major Depression, Vestibular Disorders
- **Start Date:** 2011-03
- **Completion Date:** 2012-01
- **CT.gov Last Update:** 2012-03-05

## Brief Summary

Major depression is characterized by vestibular anomalies. The investigators hypothesized that vestibular stimulation will improve depression symptoms in major depression patients.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 70 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* major depression patients,
* actual Hamilton score \> 14

Exclusion Criteria:

* pregnant,
* neurological disorders,
* epilepsy,
* bipolar disorder,
* schizophrenia,
* anorexia,
* bulimia.
```

## Interventions

- **vestibular stimulation** (OTHER) — vestibular stimulation

## Primary Outcomes

- **Hamilton depression rating score** _(time frame: 1 month after the treatment start)_

## Locations (1)

- Centro de Medicina Aeroespacial, Santiago, Santiago Metropolitan, Chile

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.centro de medicina aeroespacial|santiago|santiago metropolitan|chile` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01399671.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01399671*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*